Teresa B. Gibson, PhD

The authors provide a framework to capture additional benefits that may result from VBID programs, extending beyond utilization and outcomes to productivity, engagement, and talent.

The authors found no consistent pattern in the concordance between CER evidence and subsequent utilization patterns.

Higher patient cost-sharing is associated with a lower likelihood of treatment augmentation in patients with depression who are treated with antidepressants.

Higher cost-sharing levels reduced adherence to antidiabetic medications in patients with type 2 diabetes.

When a clinical staging algorithm for treatment-resistant depression was applied to administrative claims data, higher scores predicted higher future medical costs.

Traditional Medicare and the large-firm commercial sector have a positive correlation in hospital utilization, but a lack of correlation in spending.

Step therapy with antihypertensives may lead to medication cost savings but may have unintended effects on other medical care utilization and spending.